相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of hepatitis B vaccination in the United States, 1999-2018
Wen-Qiang He et al.
HEPATOLOGY (2022)
End stage renal disease has an early and continuous detrimental effect on regulatory T cells
Erasmia Sampani et al.
NEPHROLOGY (2022)
Heplisav-B: A Hepatitis B Vaccine With a Novel Adjuvant
Caroline R. Champion
ANNALS OF PHARMACOTHERAPY (2021)
Influence of end stage renal disease onCD28expression and T-cell immunity
Erasmia Sampani et al.
NEPHROLOGY (2021)
Enablers and barriers of maternal and neonatal immunization programs in Latin America
Alba Maria Ropero Alvarez et al.
VACCINE (2021)
The impact of the timely birth dose vaccine on the global elimination of hepatitis B
Margaret J. de Villiers et al.
NATURE COMMUNICATIONS (2021)
Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT): a randomised, double-blind, phase 3 trial
Timo Vesikari et al.
LANCET INFECTIOUS DISEASES (2021)
Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine A Phase 3 Randomized Clinical Trial
Timo Vesikari et al.
JAMA NETWORK OPEN (2021)
HLA-DPB1 alleles in hepatitis B vaccine response A meta-analysis
Guojin Ou et al.
MEDICINE (2021)
Efficacy of Birth Dose Vaccination in Preventing Mother-to-Child Transmission of Hepatitis B: A Randomized Controlled Trial Comparing Engerix-B and Sci-B-Vac
Rifaat Safadi et al.
VACCINES (2021)
Molecular Mechanisms during Hepatitis B Infection and the Effects of the Virus Variability
Marina Campos-Valdez et al.
VIRUSES-BASEL (2021)
Future Healthcare Workers and Hepatitis B Vaccination: A New Generation
Andrea Trevisan et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Hepatitis B Vaccine Non-Responders Show Higher Frequencies of CD24highCD38high Regulatory B Cells and Lower Levels of IL-10 Expression Compared to Responders
Nina Koerber et al.
FRONTIERS IN IMMUNOLOGY (2021)
An Update on Hepatocellular Carcinoma in Chronic Kidney Disease
Fabrizio Fabrizi et al.
CANCERS (2021)
Comparative Efficacy of a High-Dose vs Standard-Dose Hepatitis B Revaccination Schedule Among Patients With HIV A Randomized Clinical Trial
Jose Ignacio Vargas et al.
JAMA NETWORK OPEN (2021)
Seroprevalence of hepatitis B, hepatitis C and HIV infection among patients undergoing haemodialysis in Buenos Aires, Argentina
Matias J. Pereson et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2021)
Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination
Federico Di Lello et al.
VACCINE (2020)
Isolated Anti-HBc: Significance and Management
Florian Moretto et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Hepatitis B Immunization and Impact on Natural History and Cancer Incidence
Chih-Lin Lin et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2020)
A simple clinical score to identify likely hepatitis B vaccination non-responders - data from a retrospective single center study
Marc A. Meier et al.
BMC INFECTIOUS DISEASES (2020)
Current Knowledge of Vaccinations in Chronic Kidney Disease Patients
Intissar Haddiya
INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2020)
Elimination of Mother-to-Infant Transmission of Hepatitis B Virus: 35 Years of Experience
Fang-Ting Lu et al.
PEDIATRIC GASTROENTEROLOGY HEPATOLOGY & NUTRITION (2020)
Factors That Influence the Immune Response to Vaccination
Petra Zimmermann et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
Persistence of HBsAg-specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults
Pierre Van Damme et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Molecular epidemiology of hepatitis B virus mutants associated with vaccine escape, drug resistance and diagnosis failure
Federico A. Di Lello et al.
JOURNAL OF VIRAL HEPATITIS (2019)
Immunogenicity of a two-dose investigational hepatitis B vaccine, HBsAg-1018, using a toll-like receptor 9 agonist adjuvant compared with a licensed hepatitis B vaccine in adults
Sam Jackson et al.
VACCINE (2018)
Hepatitis B infection control in Colombian Amazon after 15 years of hepatitis B vaccination. Effectiveness of birth dose and current prevalence
Diego Garcia et al.
VACCINE (2018)
Seroprevalence of hepatitis B virus in Taiwan 30 years after the commencement of the national vaccination program
Yang-Cheng Hu et al.
PEERJ (2018)
Impaired Immune Response to Primary but Not to Booster Vaccination Against Hepatitis B in Older Adults
Birgit Weinberger et al.
FRONTIERS IN IMMUNOLOGY (2018)
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
Sarah Schillie et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Heplisav-B vaccination for the prevention of hepatitis B virus infection in adults in the United States
L. M. Splawn et al.
DRUGS OF TODAY (2018)
Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV
Y. Qin et al.
ACTA VIROLOGICA (2018)
Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China
Zhen-Zi Wang et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
A Single Center Analysis of the Positivity of Hepatitis B Antibody after Neonatal Vaccination Program in Korea
Yong Joo Kim et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2017)
Higher disappearance rate of anti-HBs in Taiwanese freshers neonatally vaccinated with recombinant yeast hepatitis B vaccine
Shu-Hua Hsu et al.
LIVER INTERNATIONAL (2017)
Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada
Chris Huynh et al.
VACCINE (2017)
Hepatitis B vaccine and the need for a booster dose after primary vaccination
Claudia Pileggi et al.
VACCINE (2017)
Influences of obesity on the immunogenicity of Hepatitis B vaccine
Fang Liu et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2017)
Immune activation, smoking, and vaccine response
Mehwish Younas et al.
AIDS (2017)
Obesity and inflammation: the linking mechanism and the complications
Mohammed S. Ellulu et al.
ARCHIVES OF MEDICAL SCIENCE (2017)
Obesity: impact of infections and response to vaccines
C. Tagliabue et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2016)
Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in Germany
Carrie L. Anderson et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2016)
A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen
Brenna C. Simons et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose
Michael G. Bruce et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Obesity Decreases B Cell Responses in Young and Elderly Individuals
Daniela Frasca et al.
OBESITY (2016)
Factors influencing immunologic response to hepatitis B vaccine in adults
Shigui Yang et al.
SCIENTIFIC REPORTS (2016)
The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in Italy
Nicola Coppola et al.
BMC INFECTIOUS DISEASES (2015)
Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1/Pre-S2/S Vaccine
Daniel Shouval et al.
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
The weight of obesity on the human immune response to vaccination
Scott D. Painter et al.
VACCINE (2015)
Characterization of an age-response relationship to GSK's recombinant hepatitis B vaccine in healthy adults: An integrated analysis
Olivier Van Der Meeren et al.
Human Vaccines & Immunotherapeutics (2015)
Recent Advances of Vaccine Adjuvants for Infectious Diseases
Sujin Lee et al.
IMMUNE NETWORK (2015)
Old and new adjuvants for hepatitis B vaccines
Geert Leroux-Roels
MEDICAL MICROBIOLOGY AND IMMUNOLOGY (2015)
Induced immunity against hepatitis B virus
Zeinab Nabil Ahmed Said et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program
Thomas J. Peto et al.
BMC INFECTIOUS DISEASES (2014)
Long-term Immune Responses to Vaccination in HIV-Infected Patients: A Systematic Review and Meta-Analysis
Solen Kerneis et al.
CLINICAL INFECTIOUS DISEASES (2014)
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Stephan Urban et al.
GASTROENTEROLOGY (2014)
A genome-wide association study identifies polymorphisms in the HLA-DR region associated with non-response to hepatitis B vaccination in Chinese Han populations
Liping Pan et al.
HUMAN MOLECULAR GENETICS (2014)
Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013
Marie Ng et al.
LANCET (2014)
Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-responsiveness to the hepatitis B vaccine
Zhaojun Duan et al.
VACCINE (2014)
Induction of a robust T- and B-cell immune response in non- and low-responders to conventional vaccination against hepatitis B by using a third generation PreS/S vaccine
Adalbert Krawczyk et al.
VACCINE (2014)
The Hepatitis B Vaccine Protects Re-Exposed Health Care Workers, But Does Not Provide Sterilizing Immunity
Jens M. Werner et al.
GASTROENTEROLOGY (2013)
Association of polymorphisms in the interleukin-4 gene with response to hepatitis B vaccine and susceptibility to hepatitis B virus infection: A meta-analysis
Wei Cui et al.
GENE (2013)
A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus A-determinant
Camille Sureau et al.
HEPATOLOGY (2013)
Determinants of Long-term Protection After Hepatitis B Vaccination in Infancy: A Meta-analysis
Katharina Schoenberger et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2013)
Observational Study of Vaccine Efficacy 24 Years after the Start of Hepatitis B Vaccination in Two Gambian Villages: No Need for a Booster Dose
Maimuna Mendy et al.
PLOS ONE (2013)
Is Obesity a Risk Factor for Vaccine Non-Responsiveness?
Katherine M. Young et al.
PLOS ONE (2013)
Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-4018) compared to a licensed hepatitis B vaccine in healthy adults 40-70 years of age
William L. Heyward et al.
VACCINE (2013)
Immunogenicity of an investigational hepatitis B vaccine (hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide) in nonresponders to licensed hepatitis B vaccine
Scott A. Halperin et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
The impact of a vaccination campaign against hepatitis B on the further decrease of hepatitis B virus infection in a southern Italian town over 14 years
Tommaso Stroffolini et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)
Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1
Jennifer A. Whitaker et al.
LANCET INFECTIOUS DISEASES (2012)
CD3Z Genetic Polymorphism in Immune Response to Hepatitis B Vaccination in Two Independent Chinese Populations
Li-Ping Pan et al.
PLOS ONE (2012)
Obesity, inflammation and the immune system
Fatima Perez de Heredia et al.
PROCEEDINGS OF THE NUTRITION SOCIETY (2012)
Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age
Scott A. Halperin et al.
VACCINE (2012)
Immune Dysfunction in Uremia-An Update
Gerald Cohen et al.
TOXINS (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
Emerging hepatitis B virus infection in vaccinated populations: a rising concern?
Tung-Hung Su et al.
EMERGING MICROBES & INFECTIONS (2012)
Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region
Y. Poovorawan et al.
JOURNAL OF VIRAL HEPATITIS (2011)
New genetic associations detected in a host response study to hepatitis B vaccine
S. Davila et al.
GENES AND IMMUNITY (2010)
Hepatitis B and Human Immunodeficiency Virus Coinfection
Chloe L. Thio
HEPATOLOGY (2009)
Development of Hepatitis B Vaccine
R. Palmer Beasley
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Antibody Levels and Protection after Hepatitis B Vaccine: Results of a 22-Year Follow-Up Study and Response to a Booster Dose
Brian J. McMahon et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Evaluation of the Impact of Hepatitis B Vaccination among Children Born during 1992-2005 in China
Xiaofeng Liang et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Mei-Hwei Chang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Long-term efficacy of plasma-derived and recombinant hepatitis B vaccines in a rural township of Central Taiwan
Jung-Ta Kao et al.
VACCINE (2009)
Levamisole is a potential facilitator for the activation of Th1 responses of the subunit HBV vaccination
Wenjuan Zhang et al.
VACCINE (2009)
Hepatitis B vaccine responses in a large US military cohort of HIV-infected individuals: Another benefit of HAART in those with preserved CD4 count
Michael L. Landrum et al.
VACCINE (2009)
Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization
Chun-Yi Lu et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Immunological response to hepatitis B vaccination in patients with AIDS and virological response to highly active antiretroviral therapy
Leilani Paitoonpong et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2008)
The global impact of vaccination against hepatitis B: A historical overview
Alessandro R. Zanetti et al.
VACCINE (2008)
Relationship between T-lymphocyte cytokine levels and sero-response to hepatitis B vaccines
Vijayakumar Velu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Hepatitis B virus infection initiates with a large surface protein-dependent binding to heparan sulfate proteoglycans
Andreas Schulze et al.
HEPATOLOGY (2007)
Impact of hepatitis B vaccination in a highly endemic area of south Italy and long-term duration of anti-HBs antibody in two cohorts of vaccinated individuals
Giuliano Da Villa et al.
VACCINE (2007)
Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination
T Bauer et al.
VACCINE (2006)
A functional polymorphism in the IL-10 promoter influences the response after vaccination with HBsAg and hepatitis A
T Höhler et al.
HEPATOLOGY (2005)
HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination
CB Wang et al.
HEPATOLOGY (2004)
Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS
RA Burdick et al.
KIDNEY INTERNATIONAL (2003)
Differential genetic determination of immune responsiveness to hepatitis B surface antigen and to hepatitis A virus:: a vaccination study in twins
T Höhler et al.
LANCET (2002)
Treatment of HBV-related liver disease in the dialysis population: reality and promises
F Fabrizi et al.
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS (2001)
Elimination of new chronic hepatitis B virus infections: Results of the Alaska immunization program
R Harpaz et al.
JOURNAL OF INFECTIOUS DISEASES (2000)
Hepatitis B virus infection in dialysis patients
F Fabrizi et al.
AMERICAN JOURNAL OF NEPHROLOGY (2000)
分享论文
